Martin Schiestl

Martin Schiestl received his doctoral degree in chemistry with a specialization in bioanalysis from the University of Innsbruck in Austria in 1996. In the same year, he started his work on Biosimilar medicines at Sandoz where he built up the analytical and pharmaceutical development departments in charge of the biosimilar pipeline and other biological medicines of Sandoz. He moved into the regulatory and policy field in 2009. In his current role, he is responsible for the Regulatory Affairs Policy of Sandoz Biopharmaceuticals.